Cargando…

Anti-SARS-CoV-2 hyperimmune immunoglobulins, an urgent strategic choice

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academie nationale de medecine 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234785/ https://www.ncbi.nlm.nih.gov/pubmed/32836229 http://dx.doi.org/10.1016/j.banm.2020.05.042

Ejemplares similares

Immunoglobulines hyperimmunes anti-SARS-CoV-2, un choix stratégique urgent
Publicado: (2020)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
por: Ali, Shaukat, et al.
Publicado: (2021)

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
por: Focosi, Daniele, et al.
Publicado: (2021)

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
por: Tang, Juanjie, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma
por: Vandeberg, Peter, et al.
Publicado: (2021)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
por: Liu, Zhuoming, et al.
Publicado: (2021)

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera
por: González Viacava, Myriam Belén, et al.
Publicado: (2022)

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma
por: Yu, Ding, et al.
Publicado: (2022)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)

Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product
por: Lachert, Elzbieta, et al.
Publicado: (2022)

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial
por: Alemany, Andrea, et al.
Publicado: (2023)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

SARS‐CoV‐2 and lung injury: Dysregulation of immune response but not hyperimmune response as in “cytokine storm syndrome”
por: Öcal, Serpil
Publicado: (2021)

Besides human booster doses: Could vaccinating highly susceptible animals to SARS-CoV-2 be the needed urgent strategic step?
por: Saied, AbdulRahman A.
Publicado: (2022)

WHO International Standard for anti-SARS-CoV-2 immunoglobulin
por: Kristiansen, Paul A, et al.
Publicado: (2021)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches
por: Stinca, Sara, et al.
Publicado: (2021)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Decisive Conditions for Strategic Vaccination against SARS-CoV-2
por: Böttcher, Lucas, et al.
Publicado: (2021)

SARS-CoV-2 Psychiatric Sequelae: An Urgent Need of Prevention
por: Bottemanne, Hugo, et al.
Publicado: (2021)

Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
por: Bihl, Florian, et al.
Publicado: (2010)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
por: Vanderven, Hillary A., et al.
Publicado: (2023)

Detection of SARS-CoV-2 variants requires urgent global coordination
por: Duarte, Carlos M., et al.
Publicado: (2021)

Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
por: Li, Entao, et al.
Publicado: (2023)

Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection
por: Zheng, Xuexing, et al.
Publicado: (2016)

Strategic Role and Challenges of Community Pharmacists in SARS-CoV-2 Outbreak
por: Talukdar, Debjyoti, et al.
Publicado: (2021)

Impact of the outbreak of SARS-CoV-2 infection on urgent gynecological care
por: Athiel, Yoann, et al.
Publicado: (2020)

The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study
por: Jiang, Yao, et al.
Publicado: (2022)

Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products
por: Cousins, Kimberley, et al.
Publicado: (2023)

Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China
por: Chen, Wei-Qing, et al.
Publicado: (2005)

Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19
por: Alape-Girón, Alberto, et al.
Publicado: (2021)

Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening
por: Tavazzi, Guido, et al.
Publicado: (2020)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q11uul12h92h1h4ifp24u9gu6v